Unjha Formulations Ltd Share Price – BSE

Pharmaceuticals, Small Cap

Unjha Formulations announced that the Annual General Meeting(AGM) of the company will be held on 14 August 2026.

Net Loss of Unjha Formulations reported to Rs 0.74 crore in the quarter ended March 2026 as against net loss of Rs 0.41 crore during the previous quarter ended March 2025. Sales rose 38.40% to Rs 3.28 crore in the quarter ended March 2026 as against Rs 2.37 crore during the previous quarter ended March 2025.

For the full year,net profit rose 70.73% to Rs 0.70 crore in the year ended March 2026 as against Rs 0.41 crore during the previous year ended March 2025. Sales rose 12.48% to Rs 15.59 crore in the year ended March 2026 as against Rs 13.86 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Unjha Formulations will hold a meeting of the Board of Directors of the Company on 18 May 2026.

Net profit of Unjha Formulations rose 9.09% to Rs 0.24 crore in the quarter ended December 2025 as against Rs 0.22 crore during the previous quarter ended December 2024. Sales rose 17.29% to Rs 4.41 crore in the quarter ended December 2025 as against Rs 3.76 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News